User: Female

Hormonal: No

Delivery Method: Vaginal Gel

Duration Type: Short-acting

Duration: Single use

Regimen:

• single

Active Pharmaceutical Ingredient (API):

• Carbopol 974P

Multipurpose Preventive Technology (MPT): Yes

Developer: ReProtect Inc.

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase III

Active Development: No

Status Details:

• Proven to be a safe, and effective contraceptive (in combination with diaphragm) in Phase III trials.

Footnotes:

• Polymers of acrylic acid cross-linked with polyalkenyl ethers or divinyl glycol.